University of Wisconsin–Madison

Martin J Dib, MD

Assistant Professor

  • Division of Transplantation

dib@surgery.wisc.edu
(608) 263-2527

Clinical Sciences Center
600 Highland Avenue
Madison, WI 53792-7375

Education

  • MD, Universidad de Chile, Santiago, Chile, 2008
  • Research Fellowship, Transplant Surgery and Liver Regeneration, Beth Israel Deaconess Medical Center, Harvard University, 2008-2009
  • Surgical Internship, Beth Israel Deaconess Medical Center, Harvard University, 2009-2010
  • Surgical Resident and Clinical Fellow, Beth Israel Deaconess Medical Center, Harvard University, 2010-2014
  • Chief Resident in General Surgery, Beth Israel Deaconess Medical Center, Harvard University, 2013-2014
  • Fellowship, Abdominal Transplant, Hepatobiliary and Pancreatic Surgery, University of Toronto, 2014-2016

Clinical Specialties

Dr. Dib is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). He specializes in liver, kidney, pancreas and pediatric transplantation, live donor liver transplantation (LDLT), and hepatobiliary surgery.

Research Interests

Dr. Dib’s research interests include the molecular basis of liver regeneration, small-for-size syndrome in live donor liver transplantation, as well as health services and outcomes research in transplant and hepatobiliary surgery.

Recent Publications:

    • Pancreas Transplantation With Portal-Enteric Drainage for Patients With Endocrine and Exocrine Insufficiency From Extensive Pancreatic Resection.
    • Barbas AS, Al-Adra DP, Goldaracena N, Dib MJ, Selzner M, Sapisochin G, Cattral MS, McGilvray ID
    • Transplant Direct 2017 Sep; 3(9): e203
    • [PubMed ID: 28894791]
    • The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization.
    • Barbas AS, Dib MJ, Rege AS, Vikraman DS, Sudan DL, Knechtle SJ, Scarborough JE
    • Ann. Surg. 2017 Jul 22;
    • [PubMed ID: 28650358]
    • Combined lung-liver-pancreas transplantation in a recipient with cystic fibrosis.
    • Barbas AS, Dib MJ, Al-Adra DP, Goldaracena N, Sapisochin G, Waddell TK, Keshavjee S, Selzner N, Chaparro C, Cattral MS
    • J. Cyst. Fibros. 2018 Jan; 17(1): e1-e4
    • [PubMed ID: 28549610]
    • Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.
    • Barbas AS, Goldaracena N, Dib MJ, Al-Adra DP, Aravinthan AD, Lilly LB, Renner EL, Selzner N, Bhat M, Cattral MS, Ghanekar A, McGilvray ID, Sapisochin G, Selzner M, Greig PD, Grant DR
    • Transplant Direct 2017 Jun; 3(6): e158
    • [PubMed ID: 28620642]
    • Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation.
    • Doyle A, Adeyi O, Khalili K, Fischer S, Dib M, Goldaracena N, Dillon J, Grant D, Cattral M, McGilvray I, Greig P, Ghanekar A, Lilly L, Renner E, Levy G, Selzner N
    • Liver Transpl. 2016 09; 22(9): 1295-300
    • [PubMed ID: 27314458]

All Publications on PubMed